Cancer

Lumitex Releases 2025 State of Medical Lighting Report

Cutting-Edge Insights for Advancing Healthcare Lighting Solutions CLEVELAND, Ohio, July 31, 2025 /PRNewswire/ -- Lumitex, a global leader in innovative…

5 months ago

Your Tumor’s Best Treatment? A Space-Based Test Could Tell You

With new NASA and NSF funding, Encapsulate is building on its ISS National Lab-sponsored research to bring personalized cancer diagnostics…

5 months ago

CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of…

5 months ago

Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology

MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have…

5 months ago

AIM ImmunoTech Announces Closing of $8.0 Million Public Offering

OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing…

5 months ago

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,…

5 months ago

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,…

5 months ago

MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline

MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapiesROCKVILLE, Md., July 31,…

5 months ago

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025

SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…

5 months ago

Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025

BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

5 months ago